Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2016 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss Fourth Quarter 2015 Financial Results

NEWARK, Calif., March 15, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for the treatment of serious central nervous...
March 14, 2016 17:19 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Closing of $8 Million Public Offering

NEWARK, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) today announced that it has closed its previously announced offering of common stock and warrants. The Company sold a...
March 09, 2016 09:23 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Pricing of Public Offering to Raise $8.1 Million

NEWARK, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) today announced the pricing of an underwritten public offering of common stock, Series A Warrants and Series B...
March 08, 2016 17:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants

NEWARK, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) today announced that it intends to offer and sell common stock, Series A Warrants and Series B Warrants, subject to...
February 26, 2016 16:05 ET | Source: StemCells, Inc.

StemCells, Inc., Pathway™ Study in Cervical Spinal Cord Injury Featured in Pittsburgh Post-Gazette

NEWARK, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system...
February 04, 2016 16:05 ET | Source: StemCells, Inc.

Ian Massey, President and CEO of StemCells, Inc., to Participate on a Regenerative Medicine Panel at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference

NEWARK, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Ian Massey, President and CEO of StemCells, Inc., will participate on a regenerative medicine...
January 28, 2016 11:15 ET | Source: StemCells, Inc.

CORRECTING and REPLACING -- StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference

NEWARK, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by StemCells, Inc. (Nasdaq:STEM), please note that in the third paragraph of the release,...
January 28, 2016 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 2016 BIO CEO Conference and Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference

NEWARK, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make presentations on the Company's programs, pipeline and operations at two...
January 11, 2016 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. CEO Martin McGlynn Passes Baton to President and COO Ian Massey

NEWARK, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system...
January 06, 2016 08:05 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 8th Annual Biotech Showcase Investor Conference

NEWARK, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the 8th...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right